Order a test
News

New tumour biobank powers personalised cancer treatments

Scientists have discovered new and more effective ways of growing breast cancer tumours that could accelerate research and the development of new treatments. Instead of transplanting human tumours into mice, they’ve developed a bank of “human patient-derived xenografts (PDXs)” that can be used to screen drugs. Used alongside personalised genetic tests could improve cancer treatment […]

Read more
News

SOTs effective at treating cancer in 77% of patients

Cancer patients treated with the highly targeted supportive oligonucleotide therapy (SOT) showed benefits in 77% of cases, RGCC scientists have found. A new paper published in the in vivo journal finds evidence that SOTs effectively target and kill cancer cells on their own or in tandem with other therapies.  Supportive oligonucleotide therapy is an advanced, […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more